Sunday, July 6, 2025
VISIT ROYALMOK
Agarwood Times
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
Agarwood Times
No Result
View All Result

On Heels of Positive Parkinson’s Gene Therapy Data, MeiraGTx Looks Ahead to Pivotal Test

October 16, 2024
in Health
Reading Time: 3 mins read
0 0
A A
0
Home Health
Share on FacebookShare on Twitter


A MeiraGTx Holdings gene remedy for Parkinson’s illness has preliminary knowledge from a small scientific trial exhibiting the one-time therapy confirmed each security and efficacy, outcomes that lay the groundwork for discussions with regulators a few Part 3 research.

The MeiraGTx gene remedy, AAV-GAD, had beforehand posted Part 1 and Part 2 outcomes exhibiting it was nicely tolerated with no vital hostile results. The outcomes introduced Tuesday are from a Part 1 bridging research designed to guage doses of AAV-GAD manufactured by London-based MeiraGTx at its personal amenities utilizing its business platform course of.

Parkinson’s sufferers lack ample quantities of a neurotransmitter referred to as dopamine. Customary therapy consists of the drug levodopa, a compound {that a} mind enzyme converts into dopamine. However dopamine substitute therapies lose efficacy over time. The motor signs of Parkinson’s may also be handled with deep mind stimulation, however that’s an invasive process.

MeiraGTx’s gene remedy is designed to spark native manufacturing of a neurotransmitter referred to as GABA, which is meant to reprogram dysfunctional mind circuits and restore extra regular exercise to cells, assuaging motor signs. The 26-week bridging research enrolled Parkinson’s sufferers who had a historical past of responsiveness to levodopa therapy for at the very least 12 months. A complete of 14 contributors had been randomly assigned to obtain a excessive dose, a low dose, or a sham therapy.

Based on MeiraGTx, AAV-GAD met the primary objective of security and tolerability with no severe hostile occasions (SAEs) reported. Efficacy, an exploratory endpoint, was evaluated by measuring motor examination scores. The corporate stated at week 26, outcomes present a statistically vital 18-point common enchancment from baseline in accordance with a ranking scale used to measure the severity and development of Parkinson’s. By comparability, no vital change was noticed within the low-dose group or the sham cohort.

“With materials made utilizing our proprietary manufacturing course of at business scale, we have now demonstrated that AAV-GAD is protected in any respect doses studied, together with a better dose than beforehand examined,” MeiraGTx President and CEO Alexandria Forbes stated in a ready assertion. “Now we have now handled a complete of 58 sufferers on this growth program in three impartial multicenter scientific research and have seen no SAEs associated to AAV-GAD therapy.”

Members who accomplished the bridging research have the choice of enrolling in a long-term follow-up research, which is able to monitor them for 5 years. In the meantime, MeiraGTx stated it plans to debate the outcomes with regulators within the U.S., Europe, and Japan because it seems to be forward to pivotal testing of the gene remedy.

MeiraGTx isn’t the one firm working to develop a one-time therapy for Parkinson’s. Bayer’s bemdaneprocel is made by engineering donor cells, turning them into dopamine-producing neurons. These cells are surgically transplanted right into a affected person’s mind the place they’re meant to switch a affected person’s misplaced dopamine manufacturing. Final 12 months, Bayer reported optimistic security and efficacy knowledge from bemdaneprocel’s Part 1 check. Final month, Bayer reported these encouraging traits continued measured at 24 months.

Aspen Neuroscience can be growing a Parkinson’s cell remedy. However in contrast to Bayer’s method, Aspen’s ANPD001 is made out of stem cells sourced from a affected person’s personal pores and skin, providing the potential to keep away from immunosuppressive medicine wanted to stop the physique from rejecting the transplanted cells. Final month, Aspen introduced it had accomplished dosing of the primary cohort of a Part 1/2a check of this cell remedy.

Picture: Dr_Microbe, Getty Pictures



Source link

Tags: AheaddatageneHeelsMeiraGTxParkinsonspivotalPositivetestTherapy
Previous Post

Avian flu strikes more California diary herds, Utah poultry flock

Next Post

How Self-Care and Wellness Evolves as You Age

Related Posts

HHS internal memo details legal strategy for grant terminations
Health

HHS internal memo details legal strategy for grant terminations

July 6, 2025
Asthma study shows patient expectations influence the course of the disease
Health

Asthma study shows patient expectations influence the course of the disease

July 6, 2025
Ireland’s first and only BioBrillouin microscope installed at Trinity College Dublin
Health

Ireland’s first and only BioBrillouin microscope installed at Trinity College Dublin

July 6, 2025
Hearing aids and cochlear implants improve social lives of adults with hearing loss
Health

Hearing aids and cochlear implants improve social lives of adults with hearing loss

July 5, 2025
Foreign medical residents fill critical positions at US hospitals, but are running into visa issues
Health

Foreign medical residents fill critical positions at US hospitals, but are running into visa issues

July 4, 2025
From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology
Health

From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology

July 5, 2025
Next Post
How Self-Care and Wellness Evolves as You Age

How Self-Care and Wellness Evolves as You Age

Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat

Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat

No evidence for belief that nut allergens spread through aircraft ventilation systems, say experts

No evidence for belief that nut allergens spread through aircraft ventilation systems, say experts

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Argon AI raises .5M for product improvement, team growth
Health

Argon AI raises $5.5M for product improvement, team growth

by admin
July 3, 2025
0

Argon AI has introduced it secured $5.5 million in seed funding. Crosslink Capital and Wireframe Ventures co-led the spherical, with...

Sniffing Out Mold’s Hidden Damage: Why Your Nose Knows Before You Do

Sniffing Out Mold’s Hidden Damage: Why Your Nose Knows Before You Do

July 1, 2025
How to Make the World’s Costliest Wood #shorts

How to Make the World’s Costliest Wood #shorts

July 4, 2025
What to Do When You Fall Off Track (Without Starting Over Again and Again)

What to Do When You Fall Off Track (Without Starting Over Again and Again)

June 30, 2025
Hearing aids and cochlear implants improve social lives of adults with hearing loss

Hearing aids and cochlear implants improve social lives of adults with hearing loss

July 5, 2025
Missing beneficial bacteria in infant guts linked to rising asthma and allergy cases

Missing beneficial bacteria in infant guts linked to rising asthma and allergy cases

July 5, 2025
Facebook Twitter Instagram Youtube RSS
Agarwood Times

Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.

CATEGORIES

  • Agarwood
  • Diet & Fitness
  • Diseases
  • Health
  • Meditation
  • Nutrition
  • Sleep Info
  • Uncategorized
No Result
View All Result

SITEMAP

  • About us
  • Advertise With Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
VISIT ROYALMOK

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In